SARS-CoV-2 Antigen Rapid Test
Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.
Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.
The World Health Organization (WHO) has just approved and listed ACON Flowflex SARS-CoV-2 Antigen Rapid Test for detecting COVID-19. WHO’s emergency use listing (EUL) procedure assesses the suitability of novel health products during public health emergencies.
ACON Biotech (Hangzhou) Co. Ltd is the first and the only manufacturer in China and the fifth manufacturer in the world to be officially recommended by WHO on the EUL list for rapid antigen detection tests.
